Literature DB >> 228565

Ultrastructural changes in Leydig cells of streptozotocin-induced diabetic rats.

J M Orth, F T Murray, C W Bardin.   

Abstract

Hyperglycemia (experimental diabetes) was induced in adult male rats by destruction of the pancreatic beta cells with a single intravenous injection of streptozotocin (STZ). Testes from diabetic, from insulin-treated diabetic, and from sham-injected normal rats were fxed by vascular perfusion. The fine structure of Leydig cells was examined at two, three, and four weeks after the STZ injection in the untreated diabetic animals, and at four weeks in the controls and insulin-treated diabetic rats. A number of morphological changes was observed in Leydig cells of untreated diabetic animals. Most obvious of these was an accumulation of lipid droplets, not normally present in Leydig cells in adults of this species. Smooth endoplasmic reticulum (SER) was markedly reduced in Leydig cells of the hyperglycemic rats. Several types of intracellular bodies were seen exclusively in Leydig cells of the untreated diabetic animals. Many resembled secondary lysosomes or dense bodies, while others appeared to be autophagic vacuoles. In addition, a small, granule-containing lamellar structure was seen either within a typical dense body or free in the cytoplasm. Myelin-like structures were commonly observed within the cytoplasm of the Leydig cell or within mitochondria. The appearance of the mitochondria in diabetic rats was otherwise normal. The extracellular spaces surrounding Leydig cells from untreated hyperglycemic rats also contained large accumulations of myelin-like material. These structural changes appear to be direct consequences of the diabetic state of the animals, since the ultrastructure of insulin-treated diabetic rats did not differ from that of the controls. These findings may reflect an alteration or breakdown of Leydig cell components normally involved in the synthesis of androgen, and correlate with previous reports of lowered circulating levels of testosterone in diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 228565     DOI: 10.1002/ar.1091950302

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  7 in total

1.  Testicular alterations in the nonobese diabetic mouse.

Authors:  Guy W Tarleton; Bernard Gondos; Brent Formby
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Antioxidant treatment with edaravone or taurine ameliorates diabetes-induced testicular dysfunction in the rat.

Authors:  Panagiota Tsounapi; Motoaki Saito; Fotios Dimitriadis; Sotirios Koukos; Shogo Shimizu; Keisuke Satoh; Atsushi Takenaka; Nikolaos Sofikitis
Journal:  Mol Cell Biochem       Date:  2012-07-05       Impact factor: 3.396

3.  Morphological changes in the hypothalamic-hypophyseal-gonadal axis of male rats after twelve months of streptozotocin-induced diabetes.

Authors:  G L Rossi; G Bestetti
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

4.  Honey and metformin ameliorated diabetes-induced damages in testes of rat; correlation with hormonal changes.

Authors:  Ozra Nasrolahi; Fereshteh Khaneshi; Fatemeh Rahmani; Mazdak Razi
Journal:  Iran J Reprod Med       Date:  2013-12

5.  Contemporaneous effects of diabetes mellitus and hypothyroidism on spermatogenesis and immunolocalization of Claudin-11 inside the seminiferous tubules of mice.

Authors:  Nazar Ali Korejo; Quanwei Wei; Kaizhi Zheng; Dagan Mao; Rashid Ali Korejo; Atta Hussain Shah; Fangxiong Shi
Journal:  BMC Dev Biol       Date:  2018-06-26       Impact factor: 1.978

6.  Cytoarchitectural improvement in Leydig cells of diabetic rats after treatment with aqueous and ethanol extracts of Dracaena arborea (Dracaenaceae).

Authors:  Modeste Wankeu-Nya; Adrian Florea; Ştefana Bâlici; Horea Matei; Pierre Watcho; Albert Kamanyi
Journal:  J Tradit Complement Med       Date:  2019-09-17

7.  The ultrastructural changes of the sertoli and leydig cells following streptozotocin induced diabetes.

Authors:  Davoud Kianifard; Rajab Ali Sadrkhanlou; Shapour Hasanzadeh
Journal:  Iran J Basic Med Sci       Date:  2012-01       Impact factor: 2.699

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.